Based on the aforementioned optimal AMH screening boundaries for PCOS in test group, the screening criteria for age-related AMH with PCOS were: ≥7.46 ng/ml (20-24-year-old), ≥ 4.55 ng/ml (25-29-year-old), ≥ 4.19 ng/ml (30-34-year-old), ≥ 3.57 ng/ml (35-39-year-old). Here, AMH is linked to polycystic ovary syndrome.